Linked e-resources

Details

Es iseases due to Other Endemic Fungi in Transplant Recipients
Cytomegalovirus
Epstein-Barr Virus Infection and Post-Transplant Lymphoproliferative Disease
Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus and Human Herpes Viruses 6, 7 and 8 in Transplant Recipients
Respiratory Viral Infections in Transplant Recipients
. Hepatitis A, B, C
Enterovirus Infection in Immunocompromised Hosts
Parvovirus B19
West Nile Virus in Immunocompromised Hosts
Rare and Emerging Viral Infections in the Transplant Population
Parasitic Infections in Transplant Recipients: Toxoplasmosis, Strongyloidiasis and Other Parasites
Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases
Diagnosis of Systemic Fungal Diseases
Viral Diagnostics
Antibiotic Consideration in Transplant Recipients
Pharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients
Antifungal Consideration for Transplant Recipients
Immunomodulatory Properties of Antifungal Agents on Immune Functions of the Host
Antiviral Consideration for Transplantation Including Drug Resistance
Pharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population
Anti-Mycobacterial Consideration in Transplantation Including Drug Non-Susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease
Adaptive Immunotherapy for Opportunistic Infections
Immunotherapy for Invasive Mold Disease in Transplant Patients – Dendritic Cell Immunotherapy, Interferon-gamma, Remcobinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions
Antimicrobial Stewardship: Considerations for a Transplant Center
The Use of Palliative Care in Organ Transplant Patients and End of Life Issues
Infection Control Strategies in Transplant Populations
Travel and Transplantation
Vaccination in Organ Transplant
Prevention of Fungal Disease
Antimicrobial Drug Prophylaxis: Challenges and Controversi.

Browse Subjects

Show more subjects...

Statistics

from
to
Export